Metzger Michael A

Director at Pyxis Oncology, Inc. · on record since Jun 10, 2024
Director at RESPONSE GENETICS INC · on record since Dec 7, 2010
Director at Syndax Pharmaceuticals Inc · on record since Jun 2, 2026
Director at Tobira Therapeutics, Inc. · on record since Dec 5, 2014
President & CEO at Tobira Therapeutics, Inc. · on record since Dec 5, 2014
Director at CTI BIOPHARMA CORP · on record since Feb 27, 2017
Chief Executive Officer at Syndax Pharmaceuticals Inc · on record since Mar 2, 2016

Insider trading activity of Metzger Michael A

Transactions on record: 157; since Apr 14, 2011

Open-market buys: 1; $1.5K

Open-market sells: 47; $16.6M

Companies traded: 5; last filing Jul 9, 2026

Figures computed from official regulatory filings — .

Companies where Metzger Michael A has traded

Syndax Pharmaceuticals Inc113 tx · $57.5M · Jul 9, 2026
Pyxis Oncology, Inc.3 tx · $36.2K · Mar 25, 2026
CTI BIOPHARMA CORP35 tx · $1.4M · Jun 26, 2023
Tobira Therapeutics, Inc.2 tx · Feb 20, 2015
RESPONSE GENETICS INC4 tx · $1.5K · Aug 1, 2012

Track record of Metzger Michael A

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Metzger Michael A

Co-insiders of Metzger Michael A

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Syndax Pharmaceuticals IncListing on record	Jul 9, 2026	Exercise	32,375	6.38 USD	$206.6K		SEC
Syndax Pharmaceuticals IncListing on record	Jul 9, 2026	Sell	-32,375	24.24 USD	$784.8K		SEC
Syndax Pharmaceuticals IncListing on record	Jul 9, 2026	ExerciseD (derivative)	32,375	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syndax Pharmaceuticals IncListing on record	Jun 2, 2026	Sell	-6,847	18.99 USD	$130K		SEC
Pyxis Oncology, Inc.Listing on record	Mar 25, 2026	AwardD (derivative)	45,867	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syndax Pharmaceuticals IncListing on record	Feb 10, 2026	Sell	-17,159	21.03 USD	$360.9K		SEC
Syndax Pharmaceuticals IncListing on record	Feb 6, 2026	Award	144,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syndax Pharmaceuticals IncListing on record	Feb 6, 2026	AwardD (derivative)	440,000	20.43 USD	$9M	Unusual size	SEC
Syndax Pharmaceuticals IncListing on record	Feb 6, 2026	Sell	-7,412	20.62 USD	$152.8K		SEC
Syndax Pharmaceuticals IncListing on record	Feb 6, 2026	Award	73,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syndax Pharmaceuticals IncListing on record	Sep 8, 2025	ExerciseD (derivative)	157,307	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syndax Pharmaceuticals IncListing on record	Sep 8, 2025	Sell	-157,307	16.41 USD	$2.6M	Unusual size	SEC
Syndax Pharmaceuticals IncListing on record	Sep 8, 2025	Exercise	157,307	10.90 USD	$1.7M	Unusual size	SEC
Syndax Pharmaceuticals IncListing on record	Jul 18, 2025	Sell	-7,534	9.29 USD	$70K		SEC
Pyxis Oncology, Inc.Listing on record	Apr 2, 2025	AwardD (derivative)	36,979	0.98 USD	$36.2K		SEC
Syndax Pharmaceuticals IncListing on record	Mar 17, 2025	ExerciseD (derivative)	6,074	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syndax Pharmaceuticals IncListing on record	Mar 17, 2025	Exercise	6,074	7.20 USD	$43.7K		SEC
Syndax Pharmaceuticals IncListing on record	Mar 6, 2025	ExerciseD (derivative)	7,814	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syndax Pharmaceuticals IncListing on record	Mar 6, 2025	Exercise	7,814	7.20 USD	$56.3K		SEC
Syndax Pharmaceuticals IncListing on record	Mar 6, 2025	Sell	-7,814	15.05 USD	$117.6K		SEC
Syndax Pharmaceuticals IncListing on record	Feb 12, 2025	Sell	-13,288	15.50 USD	$206K		SEC
Syndax Pharmaceuticals IncListing on record	Feb 7, 2025	Award	89,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syndax Pharmaceuticals IncListing on record	Feb 7, 2025	AwardD (derivative)	364,000	14.65 USD	$5.3M		SEC
Syndax Pharmaceuticals IncListing on record	Feb 7, 2025	Award	60,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Pyxis Oncology, Inc.Listing on record	Jun 10, 2024	AwardD (derivative)	70,683	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Syndax Pharmaceuticals IncListing on record	Jul 9, 2026	Exercise	32,375	6.38 USD	$206.6K		SEC
Syndax Pharmaceuticals IncListing on record	Jul 9, 2026	Sell	-32,375	24.24 USD	$784.8K		SEC
Syndax Pharmaceuticals IncListing on record	Jul 9, 2026	ExerciseD (derivative)	32,375	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syndax Pharmaceuticals IncListing on record	Jun 2, 2026	Sell	-6,847	18.99 USD	$130K		SEC
Pyxis Oncology, Inc.Listing on record	Mar 25, 2026	AwardD (derivative)	45,867	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syndax Pharmaceuticals IncListing on record	Feb 10, 2026	Sell	-17,159	21.03 USD	$360.9K		SEC
Syndax Pharmaceuticals IncListing on record	Feb 6, 2026	Award	144,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syndax Pharmaceuticals IncListing on record	Feb 6, 2026	AwardD (derivative)	440,000	20.43 USD	$9M	Unusual size	SEC
Syndax Pharmaceuticals IncListing on record	Feb 6, 2026	Sell	-7,412	20.62 USD	$152.8K		SEC
Syndax Pharmaceuticals IncListing on record	Feb 6, 2026	Award	73,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syndax Pharmaceuticals IncListing on record	Sep 8, 2025	ExerciseD (derivative)	157,307	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syndax Pharmaceuticals IncListing on record	Sep 8, 2025	Sell	-157,307	16.41 USD	$2.6M	Unusual size	SEC
Syndax Pharmaceuticals IncListing on record	Sep 8, 2025	Exercise	157,307	10.90 USD	$1.7M	Unusual size	SEC
Syndax Pharmaceuticals IncListing on record	Jul 18, 2025	Sell	-7,534	9.29 USD	$70K		SEC
Pyxis Oncology, Inc.Listing on record	Apr 2, 2025	AwardD (derivative)	36,979	0.98 USD	$36.2K		SEC
Syndax Pharmaceuticals IncListing on record	Mar 17, 2025	ExerciseD (derivative)	6,074	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syndax Pharmaceuticals IncListing on record	Mar 17, 2025	Exercise	6,074	7.20 USD	$43.7K		SEC
Syndax Pharmaceuticals IncListing on record	Mar 6, 2025	ExerciseD (derivative)	7,814	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syndax Pharmaceuticals IncListing on record	Mar 6, 2025	Exercise	7,814	7.20 USD	$56.3K		SEC
Syndax Pharmaceuticals IncListing on record	Mar 6, 2025	Sell	-7,814	15.05 USD	$117.6K		SEC
Syndax Pharmaceuticals IncListing on record	Feb 12, 2025	Sell	-13,288	15.50 USD	$206K		SEC
Syndax Pharmaceuticals IncListing on record	Feb 7, 2025	Award	89,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syndax Pharmaceuticals IncListing on record	Feb 7, 2025	AwardD (derivative)	364,000	14.65 USD	$5.3M		SEC
Syndax Pharmaceuticals IncListing on record	Feb 7, 2025	Award	60,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Pyxis Oncology, Inc.Listing on record	Jun 10, 2024	AwardD (derivative)	70,683	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC